These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 1370105)
1. Influence of the microsomal inducer and the incubation system on mutagenicity of complex mixtures. Tokiwa H; Horikawa K; Sera N Mutat Res; 1992; 276(1-2):139-44. PubMed ID: 1370105 [TBL] [Abstract][Full Text] [Related]
2. Mutagenic evaluation of trichlorfon using different assay methods with Salmonella typhimurium. Barrueco C; Herrera A; de la Peña E Mutagenesis; 1991 Jan; 6(1):71-6. PubMed ID: 2038275 [TBL] [Abstract][Full Text] [Related]
3. Aroclor-1254-induced rat-liver S9 causes chromosomal aberrations in CHO cells but not human lymphocytes: a role for active oxygen? Kirkland DJ; Marshall RR; McEnaney S; Bidgood J; Rutter A; Mullineux S Mutat Res; 1989 Sep; 214(1):115-22. PubMed ID: 2505066 [TBL] [Abstract][Full Text] [Related]
4. Human liver S-9 metabolic activation: proficiency in cytogenetic assays and comparison with phenobarbital/beta-naphthoflavone or aroclor 1254 induced rat S-9. Johnson TE; Umbenhauer DR; Galloway SM Environ Mol Mutagen; 1996; 28(1):51-9. PubMed ID: 8698047 [TBL] [Abstract][Full Text] [Related]
5. Activation of carcinogenic N-nitrosopropylamines to mutagens by lung and pancreas S9 fractions from various animal species and man. Mori Y; Yamazaki H; Toyoshi K; Maruyama H; Konishi Y Mutat Res; 1986 May; 160(3):159-69. PubMed ID: 3960034 [TBL] [Abstract][Full Text] [Related]
6. Salmonella/human S9 mutagenicity test: a collaborative study with 58 compounds. Hakura A; Shimada H; Nakajima M; Sui H; Kitamoto S; Suzuki S; Satoh T Mutagenesis; 2005 May; 20(3):217-28. PubMed ID: 15843387 [TBL] [Abstract][Full Text] [Related]
7. Conversion of procarcinogens to mutagens by the S-9 fraction from the liver of rainbow trout (Salmo gairdneri): inducibility with PCB, 3-methylcholanthrene and phenobarbital and inhibition by metyrapone and alpha-naphthoflavone. Miyauchi M Comp Biochem Physiol C Comp Pharmacol Toxicol; 1984; 79(2):363-7. PubMed ID: 6151468 [TBL] [Abstract][Full Text] [Related]
8. Mutagenicity of urine from rats after administration of 2,4-diaminoanisole: the effect of microsomal enzyme inducers. Reddy TV; Benjamin T; Grantham PH; Weisburger EK; Thorgeirsson SS Mutat Res; 1980 Dec; 79(4):307-17. PubMed ID: 7003374 [TBL] [Abstract][Full Text] [Related]
9. Alternatives in the induction and preparation of phenobarbital/naphthoflavone-induced S9 and their activation profiles. García Franco S; Domínguez G; Pico JC Mutagenesis; 1999 May; 14(3):323-6. PubMed ID: 10375000 [TBL] [Abstract][Full Text] [Related]
10. The spectrum of enzymes involved in activation of 2-aminoanthracene varies with the metabolic system applied. Veres Z; Török G; Tóth E; Vereczkey L; Jemnitz K Mutat Res; 2005 Sep; 586(1):18-27. PubMed ID: 16006184 [TBL] [Abstract][Full Text] [Related]
11. Mutagenicity of structurally related aromatic amines in the Salmonella/mammalian microsome test with various S-9 fractions. Shahin MM; Chopy C; Mayet MJ; Lequesne N Food Chem Toxicol; 1983 Oct; 21(5):615-9. PubMed ID: 6360828 [TBL] [Abstract][Full Text] [Related]
12. Effect of dietary casein levels on activation of promutagens in the spiral Salmonella mutagenicity assay. II. Studies with induced rat liver S9. Woodall GM; Dauterman WC; DeMarini DM Mutat Res; 1996 Jun; 360(2):127-43. PubMed ID: 8649465 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of phenobarbital/beta-naphthoflavone as an alternative S9-induction regime to Aroclor 1254 in the rat for use in in vitro genotoxicity assays. Callander RD; Mackay JM; Clay P; Elcombe CR; Elliott BM Mutagenesis; 1995 Nov; 10(6):517-22. PubMed ID: 8596471 [TBL] [Abstract][Full Text] [Related]
14. Host-mediated mutagenicity experiments with benzo[a]pyrene and two of its metabolites. Glatt H; Bücker M; Platt KL; Oesch F Mutat Res; 1985 Jun; 156(3):163-9. PubMed ID: 3889634 [TBL] [Abstract][Full Text] [Related]
15. Interaction with microsomal lipid as a major factor responsible for S9-mediated inhibition of 1,8-dinitropyrene mutagenicity. Shah AB; Combes RD; Rowland IR Mutat Res; 1991 Jul; 249(1):93-104. PubMed ID: 2067546 [TBL] [Abstract][Full Text] [Related]
16. Activation and detoxication of promutagens by toadfish (Opsanus tau) hepatic postmitochondrial fractions in the Salmonella assay. Milling DM; Maddock MB Mutat Res; 1986 Apr; 164(2):81-9. PubMed ID: 3515163 [TBL] [Abstract][Full Text] [Related]
17. Activation of pro-mutagens in complex mixtures by rat liver S9 systems. Courtois YA; Pesle ML; Festy B Mutat Res; 1992; 276(1-2):133-7. PubMed ID: 1370104 [No Abstract] [Full Text] [Related]
18. Stability of microsomal mono-oxygenase during incubations for the liver microsomal assay with S9 fractions of mouse liver under various inductions. Paolini M; Bauer C; Corsi C; Del Carratore R; Nieri R; Bronzetti G Mutat Res; 1983 Aug; 110(2):221-30. PubMed ID: 6877256 [TBL] [Abstract][Full Text] [Related]
19. Salmonella mutagenicity of three complex mixtures assayed with the microsuspension technique. A WHO/IPCS/CSCM study. Agurell E; Stensman C Mutat Res; 1992; 276(1-2):87-91. PubMed ID: 1370111 [TBL] [Abstract][Full Text] [Related]
20. The differential mutagenicity of isoniazid in fluctuation assays and Salmonella plate tests. Gatehouse D; Wedd DJ Carcinogenesis; 1984 Mar; 5(3):391-7. PubMed ID: 6368032 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]